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Background: Among the rare neurological complications of substances of abuse is the selective cerebral white
matter injury (leukoencephalopathy). Of which, the syndrome of delayed post hypoxic encephalopathy (DPHL) that
follows an acute drug overdose, in addition to “chasing the dragon” toxicity which results from chronic heroin vapor
inhalation remain the most commonly described syndromes of toxic leukoencephalopathy. These syndromes are
reported in association with opioid use. There are very few cases in the literature that described leukoencephalopathy
following benzodiazepines, especially with an acute and progressive course. In this paper, we present a patient who
developed an acute severe fatal leukoencephalopathy following hypoxic coma and systemic shock induced by
benzodiazepine overdose.
Case presentation: A 19-year-old male was found comatose at home and brought to hospital in a deep coma, shock,
hypoxia, and acidosis. Brain magnetic resonant imaging (MRI) revealed a strikingly selective white matter injury early in
the course of the disease. The patient remained in a comatose state with no signs of neurologic recovery until he died
few weeks later following an increase in the brain edema and herniation.
Conclusion: Toxic leukoencephalopathy can occur acutely following an overdose of benzodiazepine and respiratory
failure. This is unlike the usual cases of toxic leukoencephalopathy where there is a period of lucidity between the
overdose and the development of white matter disease. Unfortunately, this syndrome remains of an unclear
pathophysiology and with no successful treatment.
Keywords: Delayed post-hypoxic leukoencephalopathy, Leukoencephalopathy, Benzodiazepines, Alprazolam,
Coma, Hypoxia, Herniation, Demyelination, Acidosis, Toxin, Drugs of abuseBackground
Leukoencephalopathies constitutes a group of neuro-
logical disorders characterized by diffuse damage to the
cerebral white matter with relative sparing of the gray
matter. In addition to the known genetic and metabolic
syndromes, this entity has been associated with the use
of different chemicals; the list includes therapeutic medi-
cations e.g. chemotherapy agents [1], toxins as in the
case of carbon monoxide poisoning [2] or recreational
drugs. Opioids are known to cause a picture of leukoen-
cephalopathy since 1970s [3]. They are known to cause
two distinct clinical syndromes depending on the context.* Correspondence: faalhussain@ksu.edu.sa
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less otherwise stated.The first is subacute/chronic neurologic decline with
leukoencephalopathy that is associated with the chronic
use of heroin vapor or the so called chasing the dragon
toxicity (as this specific type of opioid preparation is
known among the users as “chasing the dragon”) [4].
The other syndrome is less common and –typically-
manifests itself as delayed manifestations few weeks
following a near-complete recovery from a reversible
hypoxic coma caused by opioid overdose. The latter
condition is known in the literature as delayed post-
hypoxic leukoencephalopathy (DPHL) [5-10]. It was
also seen following other causes of coma like carbon
monoxide poisoning [11] or cocaine [4].
Here, we present a patient who developed an un-
usually acute fatal leukoencephalopathy after an episode
of hypoxic coma induced by an overdose of alprazolam.ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribu-
ed the original work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article, un-
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were aware of only two publications of leukoencephalopa-
thy associated with the sole use of benzodiazepines [8,12].
Case presentation
A 19-year-old male was brought to the emergency room
after being found unconscious at home. His father found
him unresponsive with irregular noisy breathing and
frothy salivation. An empty pack of Alprazolam (Xanax)
was noted beside his bed. His father did not notice any
jerky movements or classic seizure manifestation. The
family denied any history of trauma, headache or seizures.
Apart from easy irritability, tendency to spend most the
time alone and sleep difficulties, the patient did not have
major psychiatric disorder. He was a cigarette smoker and
might have used illicit drugs. His past medical history was
unremarkable apart from bronchial asthma exacerbations
that necessitated admissions during his early childhood
with no recurrence in adulthood.
Upon arrival, he was in deep coma (Glasgow Coma
Scale score of 3 out of 15) with bilateral pinpoint unre-
active pupils. There was no spontaneous voluntary or
involuntary movement noted. He was hypotensive (sys-
tolic blood pressure of 70–80 mmHg), tachycardiac (heart
rate of 132 beats/minute) and tachypniec (respiratory rate
of 23 breaths/minute). His core body temperature was
38.8°C and oxygen saturation by pulse oximetry was 71%.
Exam showed generalized hypotonia, diminished reflexes,
absent plantar response with no meningeal signs. He had
one episode of coffee-ground vomiting.
He was intubated, mechanically ventilated and resusci-
tated with intravenous fluids, vasopressors and inotropes
(norepinephrine and dopamine). Arterial blood gases
showed a picture of respiratory and metabolic acidosis
(pH: 7.1, pCO2: 64.2 mmHg, PO2 57.8 mmHg and
HCO3 20.9 mEq/L). His complete blood count showed
leukocytosis (white blood cells count of 27.5 × 10e9/L,
(80% neutrophils), a hemoglobin of 14.8 mg/dl, and plate-
let count of 214 × 10e9/L. He had acute kidney injury
(creatinine 206 umol/L) with hyperkalemia (5.7 mmol/L).
His liver function test showed highly elevated transami-
nases (aspartate aminotransferase of 326 U/L, alanine
aminotransferase of 326 U/L) with normal alkaline
phosphatase (ALP), gamma-glutamyltransferase (GGT),
bilirubin and albumin. Coagulation profile showed INR
of 2 with prolongation of PT and APTT. His serum cre-
atine phosphokinase (CPK) level was 4858 U/L.
A chest X-ray done in the day of presentation showed
an evidence of bilateral lung infiltrates more in the left
side. A computed tomography (CT) scan of the brain
without contrast done in the same day did not reveal
any hemorrhage, space occupying lesion or territorial
infarction. The brain parenchyma looked normal with
preserved grey-white matter differentiation (Figure 1A).His urine tested highly positive for benzodiazepines
(>1000 ng/mL) and tetrahydrocannabinol (THC >100 ng/
mL) while it did not show any traces of opioids, ethanol,
amphetamines or cocaine. His plasma benzodiazepine
level was 56.5 ng/mL. The patient was transferred to
the ICU with the diagnoses of drug overdose, acute
kidney injury, acute liver injury (toxic versus ischemic),
aspiration pneumonia with respiratory failure and septic
shock. Supportive measures were continued and antibi-
otics, intravenous proton pump inhibitors, vitamin K,
fresh frozen plasma were given.
The next day, the patient improved in terms of
hemodynamics and respiratory condition. His level of
consciousness slightly improved as he started to open his
eyes spontaneously, blinked to visual threat, extended his
arms to painful stimulus but was not following commands
and there was no verbal output. His blood leucocyte count
started to subside gradually, and his liver function tests,
urea and creatinine returned to near-baseline within days.
All of his blood and sputum cultures did not grow any
organisms. Human immunodeficiency virus (HIV) anti-
bodies were negative by Enzyme-linked immunosorbent
assay (ELISA) and the screening for hepatitis B and C
was also negative. He had an episode of generalized
tonic-clonic convulsion and levetiracetam was started
via nasogastric tube.
Electroencephalography (EEG) was done at the same
day of the seizure which revealed a diffuse severe slow-
ing of background at 2–3 Hz of low voltage. However,
there was no focality, asymmetry or epileptic abnormal-
ities. Transthoracic echocardiography was done which
showed an evidence of biventricular moderate to severe
global systolic dysfunction.
Clinically, there was no further improvement noted in
the following three days.
In the fifth day of admission, he was found to have fixed
dilated left pupil and normal reactive right one. His level
of consciousness was the same. Physical examination
showed generalized hypotonia with bilateral extensor
plantar responses. Intravenous mannitol was given and
urgent CT scan of the brain showed a clear generalized
diffuse hypodensity involving the subcortical white matter
(Figure 1B). MRI brain done in the 7th day of admission
which showed diffuse white matter changes with sparing
of the brain stem and cerebellum (Figures 2 and 3).
The patient spent 3 weeks intubated in the intensive
care unit with full supportive care while his level of con-
sciousness stayed at Glasgow come scale of 7 (opening
eyes spontaneously and extending limbs to pain).
In the 23rd day of admission, the patient had bilat-
erally dilated unreactive pupils with absence of brainstem
reflexes. CT scan of the brain showed increasing in the
white matter hypodensity with evidence of tonsillar her-
niation and subsequent new left occipital infarction in the
Figure 1 Brain CT scans throughout the hospital stay. A) admission CT scan showing an unremarkable brain parenchyma with preserved grey-white
matter demarcation. There was also small left frontal scalp hematoma (not shown). B) A follow-up CT showing decreasing attenuation of the white
matter diffusely. C) CT done 3 weeks of admission following patient clinical deterioration revealing evidence of progressive diffuse hypoattenuation the
cerebral white matter, basal ganglia and thalami bilaterally. There is left occipital gray-white matter hypodensity consistent with infarct, explained by
trantentorial herniation trapping the left posterior cerebral artery against tentorium cerebelli.
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clared brain dead after fulfilling the brain death criteria.
Conclusions
The MRI findings in our case shows extensive selective
white matter damage with sparing of the gray matter.
Strikingly, the brainstem and cerebellum were totally
spared. Such findings resemble the cases of delayed postFigure 2 Magnetic resonant images of the brain. A-C) FLAIR images show
hyperintense foci are seen in globus pallidus bilaterally which is likely ische
D-F) Post contrast T1 weighted images show minimal patchy enhancemenhypoxic leukoencephalopathy related to carbon monoxide
or opioids overdose. The findings were more pronounced
in the diffusion MRI sequences which suggest an acute-
ness of the illness.
The syndrome of post-hypoxic leukoencephalopathy
occurs as a consequence of hypoxia that is brought by
different causes. Most commonly, hypoxia induced by
carbon monoxide poisoning [2] or opioid overdose,s diffusely increased signal intensity in cerebral white matter. Small
mic secondary to hypoxia. Left frontal scalp hematoma is seen.
t is seen in cerebral white matter.
Figure 3 Diffusion weighted images (DWI). DWI in the upper row and apparent diffusion coefficient (ADC) maps in the lower row show areas of
diffuse and symmetric diffusion restriction in the cerebral subcortical white matter and right globus pallidus that is corresponding to the changes
seen in FLAIR images. Note the sparing of infratentorial structures.
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medically-used opioids for anesthesia or oral analgesia
[5,9,10,13,14]. However, it was also described in associ-
ation with cocaine [15] and benzodiazepine overdose
[4,8]. To a lesser extent, this syndrome of post hypoxic
leukoencephalopathy was also reported following car-
diorespiratory arrest, shock [3,15-17] and metabolic
coma e.g. hepatic, hyper or hypoglycemic [15]. In the
next text, we will review the different presentation of
toxic related hypoxic leukoencephalopathy.
After reviewing the literature, two types of post
hypoxic leukoencephalopathy can be distinguished in
relation to onset of symptoms after hypoxia. The more
common is the delayed type (delayed post hypoxic
leukoencephalopathy, DPHL), where the patient recovers
to baseline after the coma and respiratory arrest with
normal brain imaging initially (if done) and usually is sent
home [5,6,9,16]. Afterwards, following a lucid period
(>12 days) of return to normal function, the clinical
manifestations appears with radiological evidence of
diffuse leukoencephalopathy. The other less common
type is the early or acute type where the patient's brain
imaging shows an evidence of leukoencephalopathy in
the first few days after the initial event without notable
period of recovery [3,4,15,18]. In the next paragraphs,
our main focus will be on the delayed type as it is more
commonly described in the literature and it might share
the same underlying pathophysiologic mechanism.
In the majority of cases, the patient is typically hospi-
talized with respiratory failure and coma induced by an
overdose of opioids [5,6,9,16]. After supportive treatment,patient enjoys a period of full recovery and is usually dis-
charged home. Brain imaging at this stage fails to find any
significant abnormalities with normal white matter signal
[8,16]. Days/weeks later (from 12 days to 5 weeks), the
patient is then brought with deterioration in neuro-
logical status that is manifested mainly by severe cognitive
and behavioral changes e.g. odd behavior, personality
changes, confusion, memory problems, mutism, hemine-
glect, catatonia, automatisms, incontinence, abnormal
movement and/or gait difficulties [6-10,16]. Those symp-
toms are associated with the presence of abnormal neuro-
logical signs e.g. prominent pyramidal, extrapyramidal
and/or cerebellar signs [4-10,13,19]. Occasionally, patient
may progress to quadreparesis (typically spastic), stupor
and coma [7,9]. Gottfried described a patient who had seg-
mental myoclonus as part of DPHL [7].
Our patient didn’t have lumbar puncture. In patients
of DPHL, routine cerebrospinal fluid (CSF) studies (cell
count, protein and glucose) are typically normal with
negative microbiologic cultures and no evidence of
infection including JC virus[10,18], herpes simplex virus
(HSV) [5] and Epstein–Barr virus (EBV) [13]. Also, oli-
goclonal bands are usually absent and CSF IgG levels are
within normal [5-8,13]. Shprecher et al. found an evidence
of demyelination with elevated CSF myelin basic protein
in a patient who had DPHL following opioid-induced
coma [13]. EEG classically shows diffuse non-specific slow
waves without characteristic findings [5,8,9,13].
The characteristic MRI findings in DPHL include
diffuse white matter hyperintensities on T2 sequences
involving the periventricular white matter bilaterally
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areas [10,11,20]. Classically, in cases of DPHL, these
lesions are restricted to the periventricular subcortical
white matter, sparing the cerebellum or the brain stem
[4,6,7,13,16,19] and doesn't enhance after contrast ad-
ministration. On diffusion weighted imaging (DWI), there
is a symmetric decrease in the apparent diffusion coeffi-
cient (ADC) values in the corona radiata and the centrum
semiovale white matter [15]. In addition to areas of
restricted water diffusion in both globus pallidi which are
usually evident as hypodensities in CT scan [4]. DPHL
Cases caused by carbon monoxide poisoning had also
the same involvement of periventricular white matter,
centrum semiovale and also sparing of the infratentorial
structures [2]. This finding might help in differentiating
DPHL from the chronic heroin vapor inhalation leukoen-
cephalopathy (chasing-the-dragon toxicity) where there is
usually involvement of the infratentorial structures, mainly
brainstem and cerebellum [4,21].
Magnetic Resonance Spectroscopy (MRS) in the re-
ported cases of DPHL showed a picture similar to de-
myelination with an elevated choline peak, increased
choline to creatine ratio, elevated lactate and decreased
N-acetylaspartate (NAA) [4,7,16]. MRS in heroin vapor
(chasing the dragon) toxicity is different, as is showed
reduced choline peak, reduced NAA and elevated lactate
in previous case reports [4,21].
Pathological studies showed widespread demyelination,
with the myelin being replaced by lipid laden macro-
phages which gives the brain a spongiotic appearance
[9]. However, cerebral cortex, putamen, thalamus, hippo-
campus, brain stem, and cerebellum are usually normal
in cases of post-hypoxic leukoencephalopathy [9]. There
is no acute of chronic inflammatory changes or white
matter necrosis [3,7,9,22]. Occasionally, there is bilateral
globus pallidus necrosis that’s is attributed to prolonged
hypoxia [3].
The pathophysiology of this phenomenon remains
poorly understood. Despite the numerous cases of drug
overdose and hypoxic-ischemic brain injury encountered
in daily medical practice, this condition remains gener-
ally rare. Hence, hypoxia-ischemia alone or opioid over-
dose alone is not sufficient to explain the unusual
selective white matter damage. We believe that this condi-
tion will be better explained by a “double hit” mechanism
where there is an inherent pre-predisposition leading to a
susceptible myelin or myelin-forming cells. This theory
was enforced when some patients with DPHL found to be
partially deficient of arylsulfatase A, an enzyme which its
complete absence causes accumulation of sulfatides in the
myelin producing cells and subsequent leukodystrophy
(metachromatic leukodystrophy, MLD) [7,23]. This notion
was challenged by the finding of other patients with DPHL
but with normal arylsulfatase A level [8,10,19]. This leadsto other authors suggesting different mechanisms trying
to explain the delayed onset of symptoms. Heckmann
et al. attributed the biphasic course to the slower necrosis
of myelin sheath given the longer half-life of myelin that
follows the immediate death of myelin-producing glial
cells at the border zones of the white matter, which is less
perfused compared to gray matter [19,24]. Although the
majority of patients with post-hypoxic leukoencephalopa-
thy following drug overdose are of the delayed type, it is
unclear why do some patients develop early/acute disease.
In the case of our patient, he was brought with severe hyp-
oxia, hypercapnia, acidosis and multiorgan failure which
could imply prolonged period of hypoxia and hypoper-
fusion. This patient is similar to 3 other patients in the
literature (see patient #1 [3], patient #2 [18] patient #3 [4])
where the findings appeared earlier in the disease course
and there was no recovery to baseline. Our patient and
the other three share some features including the un-
known duration of coma/hypoxia, late presentation, and
evidence of hemodynamic shock and fever. This is in con-
trast to the majority of cases of delayed presentation
DPHL, the hypoxic event (mild-moderate), coma and ICU
stay is usually brief (1–3 days) and patients rarely necessi-
tate aggressive resuscitation or inotropic support [4,10].
We assume that in a patient who has some predisposition
to leukoencephalopathy (e.g. genetic, use of drugs), a pro-
longed hypoxia, delayed onset of resuscitation, and/or
multiorgan failure might be a risk factor for the early de-
velopment of leukoencephalopathy. And those patients
generally do poorly compared to typical DPHL likely due
the presence of an accompanying hypoxic anoxic enceph-
alopathy from the prolonged hypoxia and hypoperfusion.
The role of cannabis in our case is unclear, but we
believe it is of a less significance than benzodiazepines
for the following reasons; the first being cannabis is
known to cause coma only in the children. Secondly, the
amount of the THC found in our patient is relatively
small and is not typically associated with decrease level
of consciousness. For example, Carstairs et al. reported a
14-month-old girl who had decreased level of conscious-
ness (GCS 7) secondary to accidental cannabis ingestion.
Her urinary THC-COOH level was 3844 ng/mL and her
clinical improvement coincided with a marked decline
in the level of urinary THC-COOH to 203 ng/mL [25].
Lastly, the patient was intoxicated with another well-
known CNS depressant in a significantly higher quantity
which better accounts for the clinical picture. Neverthe-
less, it is not possible, at this point, to totally eliminate
an undescribed role of THC in the pathogenesis of
leukoencephalopathy.
Due to the limited number of cases and the poorly
understood pathophysiology, no single treatment is shown
to be effective and the management remains mainly
symptomatic and supportive e.g. antispasticity measures,
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prednisolone [7] and coenzyme Q [4] have been tried with
no significant effect.
The majority of DPHL patients in the previous case
reports had a course of slow recovery to near baseline.
Within weeks, they gradually start to regain some of the
functions e.g. speech, ambulate. After 1–2 years, the
majority return back to their baseline with some re-
sidual cognitive dysfunction (e.g. short-term memory)
or fatigue which might render them dependent. Rarely,
the patient could have progressive neurological deteri-
oration that eventually lead to death within few weeks
from the onset of the delayed phase [9]. The MRI changes
usually resolve by this time but with an evidence of diffuse
cortical atrophy [5-8,10,13,15].
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A written informed consent was obtained from the pa-
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available for review by the editor of this journal.
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